Table 1.
Clinical and hemodynamic characteristics of patients with PH.
| Characteristics | Values | |
|---|---|---|
| Baseline Parameters (Mean ± SD) | ||
| Age (years) | 47.75 ± 14.87 | |
| Disease duration (years) | 3.55 ± 7.02 | |
| Gender (male/female) | 13/42 | |
| Body mass index (kg/m2) | 23.94 ± 3.87 | |
| Body surface area (m2) | 1.65 ± 0.15 | |
| BNP (pg/mL) | 289.67 ± 268.97 | |
| Clinical classification of PH (n) | ||
| I | 12 (21.8%) | |
| II | 6 (10.9%) | |
| III | 10 (18.2%) | |
| IV | 15 (27.3%) | |
| V | 12 (21.8%) | |
| Class of mPAP (n) | ||
| Mild (25–39 mm Hg) | 21 (38.2%) | |
| Severe (≥70 mm Hg) | 34 (61.8%) | |
| Class of sPAP (n) | ||
| Mild (44–55 mm Hg) | 8 (14.5%) | |
| Severe (≥55 mm Hg) | 47 (85.4%) | |
| NYHA classification (n) | ||
| I | 11 (20.0%) | |
| II | 20 (36.4%) | |
| III | 22 (40.0%) | |
| IV | 2 (3.6%) | |
| Hemodynamics (mean ± SD) | ||
| sPAP (mmHg) | 68.35 ± 20.62 | |
| dPAP (mmHg) | 35.65 ± 42.53 | |
| mPAP (mmHg) | 42.82 ± 12.74 | |
| CO (l/min) | 4.64 ± 2.54 | |
| PCWP (mmHg) | 6.86 ± 4.79 | |
| PVR (dynes.sec.mm−5) | 979.03 ± 594.73 | |
Note. BNP, B-type natriuretic peptide; CO, cardiac output; dPAP, pulmonary artery diastolic pressure; mPAP, mean pulmonary artery pressure; NYHA, New York Heart Association; PCWP, pulmonary capillary wedge pressure; PH, pulmonary hypertension; PVR, pulmonary vascular resistance; sPAP, pulmonary artery systolic pressure.